Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Metacrine, Inc. (MTCR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/24/2023 |
4
| Klassen Preston (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 842,211 shares
@ $0.47, valued at
$395.8k
Disposed/sold 842,211 options to buy
@ $0.47, valued at
$395.8k
|
|
| 01/27/2023 |
4
| York Michael (Chief Business Officer) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 107,054 shares
@ $0.4141, valued at
$44.3k
|
|
| 01/27/2023 |
4
| Klassen Preston (President & CEO) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 380,605 shares
@ $0.4132, valued at
$157.3k
|
|
| 12/21/2022 |
4
| Leonard Braden Michael (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Bought 101,384 shares
@ $0.4, valued at
$40.6k
Bought 50,122 shares
@ $0.3791, valued at
$19k
Bought 120,099 shares
@ $0.4, valued at
$48k
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Nashat Amir (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| JONKER JEFFREY DAVID (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| McHutchison John G (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| Owens Julia C. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| Evans Ronald M (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| GUGGENHIME ANDREW (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 04/20/2022 |
4
| Klassen Preston (President & CEO) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 43,575 shares
@ $0.5021, valued at
$21.9k
Sold 1,173 shares
@ $0.5056, valued at
$593.1 |
|
| 04/18/2022 |
4
| Klassen Preston (President & CEO) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 104,500 shares
@ $0 |
|
| 03/01/2022 |
4
| Klassen Preston (President & CEO) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 842,211 shares
@ $0
Granted 842,211 options to buy
@ $0.47, valued at
$395.8k
|
|
| 03/01/2022 |
4
| York Michael (Chief Business Officer) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 210,553 shares
@ $0
Granted 210,553 options to buy
@ $0.47, valued at
$99k
|
|
| 12/27/2021 |
4
| Walker Paul Edward (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| Sonsini Peter W. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| Makhzoumi Mohamad (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| Chang Carmen (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 12/27/2021 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 10/26/2021 |
4
| venBio Global Strategic Fund, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 75,035 shares
@ $1.6383, valued at
$122.9k
Sold 540,667 shares
@ $1.4907, valued at
$806k
|
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Evans Ronald M (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $4.07, valued at
$67.2k
|
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|